{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q8NBP7",
      "entity_text" : "PCSK9",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:10090" ],
      "TissueType" : [ "tissuelist:TS-0091" ]
    }
  },
  "verbose_text" : "Western blotting revealed that the protein level of PCSK9 was signifi-cantly lower in PCSK9 shRNA therapy group than those in the HFD-MCAO group and the analysis on the IHC staining indicated that the gray scale of PCSK9 in the PCSK9 shRNA pretreated group was higher than in the HFD-MCAO group.",
  "reading_complete" : "2020-08-03T18:07:47Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T18:07:10Z",
  "trigger" : "level",
  "evidence" : [ "level of PCSK9" ],
  "pmc_id" : "6108876",
  "score" : 0
}